At this motor show, with the booth concept of «Live Outside the Box,» Honda will propose
its original mobility products generated from Honda's innovative inspirations unbound by precedent or conventional wisdom.
ew data presented today at the European League Against Rheumatism Annual Congress (EULAR 2014) show that the newly - approved infliximab biosimilar CT - P13 achieves statistically similar improvements in disease activity, disability and
mobility in patients with Ankylosing Spondylitis (AS) compared to its
original reference
product infliximab (INX).